[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2022）
摘要
The inclusion of piribedil (150-250 mg/day) in the 6-months therapy reduces the dysfunction of the upper gastrointestinal tract (by 61 and 74% of the initial level of dysphagia and sialorrhea, respectively) regardless the drug use in monotherapy or in complex therapy with levodopa.
更多查看译文
关键词
Parkinson’s disease,dopamine receptor agonists,gastrointestinal dysfunction,piribedil,quality of life,salivation,swallowing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要